HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.

Abstract
The evolutionarily conserved Mre11-Rad50-Nbs1 (MRN) complex, consisting of proteins encoded by the genes Mre11, Rad50, and Nbs1, was recently shown to play a crucial role in DNA double-strand break (DSB) repair by recruiting the nuclear protein kinase ataxia telangiectasia mutated to DSB sites, leading to activation of this DNA repair network. Given the fact that carriers of defective mutation and polymorphic variants of ataxia telangiectasia mutated are at higher risk of developing breast cancer, we hypothesized a role of the MRN genes in determining breast cancer susceptibility. This hypothesis was examined both in a case control study of 559 breast cancer patients and 1,125 healthy women of single-nucleotide polymorphisms in Mre11, Rad50, and Nbs1 and by the in vivo detection of binding between Mre11 and BRCA1, encoded by the breast cancer susceptibility gene BRCA1. We were also interested in defining whether any association between MRN genes and breast cancer was modified by reproductive risk factors reflecting the level of estrogen exposure or susceptibility to estrogen exposure, as estrogen is known to initiate breast cancer development due to its metabolites causing DSB formation. Support for the hypothesis came from the observations that (a) one single-nucleotide polymorphism in Nbs1 was significantly associated with breast cancer risk, and a trend toward an increased risk of developing breast cancer was found in women harboring a greater number of putative high-risk genotypes of MRN genes (an adjusted odds ratio of 1.25 for each additional putative high-risk genotype; 95% confidence interval, 1.10-1.44); (b) this association between risk and the number of putative high-risk genotypes was stronger and more significant in women thought to be more susceptible to estrogen, i.e., those with no history of full-term pregnancy, those older (>or=26 years of age) at first full-term pregnancy, or those having had fewer (<2) full-term pregnancies; the risk effect conferred by harboring a higher number of high-risk genotypes of MRN genes was more significant in women without a history of breast feeding; and (c) Mre11 and BRCA1 were shown to form a complex in vivo, and this interaction was increased by irradiation. This study supports the role of the MRN pathway in breast cancer development, further strengthening the suggestion that mechanisms regulating DSB repair may play a mutator role driving breast cancer pathogenesis.
AuthorsHuan-Ming Hsu, Hui-Chun Wang, Sou-Tong Chen, Giu-Cheng Hsu, Chen-Yang Shen, Jyh-Cherng Yu
JournalCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (Cancer Epidemiol Biomarkers Prev) Vol. 16 Issue 10 Pg. 2024-32 (Oct 2007) ISSN: 1055-9965 [Print] United States
PMID17932350 (Publication Type: Journal Article)
Chemical References
  • BRCA1 Protein
  • BRCA1 protein, human
  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Genetic Markers
  • MRE11 protein, human
  • NBN protein, human
  • Nuclear Proteins
  • MRE11 Homologue Protein
  • Acid Anhydride Hydrolases
  • Rad50 protein, human
  • DNA Repair Enzymes
Topics
  • Acid Anhydride Hydrolases
  • Adult
  • Aged
  • BRCA1 Protein (genetics)
  • Breast Neoplasms (genetics)
  • Carcinoma, Ductal (genetics)
  • Case-Control Studies
  • Cell Cycle Proteins (genetics)
  • DNA Breaks, Double-Stranded
  • DNA Repair (genetics)
  • DNA Repair Enzymes (genetics)
  • DNA-Binding Proteins (genetics)
  • Female
  • Genetic Markers (genetics)
  • Genetic Predisposition to Disease (genetics)
  • Genotype
  • Humans
  • Linkage Disequilibrium
  • MRE11 Homologue Protein
  • Middle Aged
  • Nuclear Proteins (genetics)
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide (genetics)
  • Risk Factors
  • Statistics as Topic
  • Taiwan

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: